XML 25 R13.htm IDEA: XBRL DOCUMENT

CONCENTRATION OF RISK	3 Months Ended
CONCENTRATION OF RISK	Mar. 31, 2017
Risks and Uncertainties [Abstract]
Concentration of Risk	CONCENTRATION OF RISK Customer and Credit Concentration Risk The Company provides trade credit to its customers in the normal course of business. One commercial payor, United Healthcare, accounted for approximately 22.8% and 26.0% of revenue during the three months ended March 31, 2017 and 2016, respectively. This contract will terminate effective September 30, 2017. In addition, Medicare accounted for approximately 6.9% and 7.3% of revenue during the three months ended March 31, 2017 and 2016, respectively. Therapy Revenue Concentration Risk The Company sells products related to the Immune Globulin therapy, which represented 22.2% and 17.1% of revenue for the three months ended March 31, 2017 and 2016, respectively.